SEC Form D filing

FibroBiologics, Inc., 2025-12-03

An SEC Form D private-offering notice from Houston, TX, a $4,000,000 filer-stated offering target in Biotech. Filed 2025-12-03. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

FibroBiologics, Inc. site↗ Verified via SEC Form D

Clinical stage cell therapy company developing fibroblast based treatments for chronic diseases including multiple sclerosis and disc degeneration.

Filed 2025-12-03Filed to raise $4,000,000First money in 2025-11-18Raised so far $4,000,000HQ (as filed) Houston, TXSector Biotech web-verified against the company’s own siteStage (inferred) Seed
Source linked the Form D on EDGAR↗Website verified fibrobiologics.com↗Named in the filing 7 executives & directors
Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Also filed for this raise

every source Form D behind this opportunity
  • FibroBiologics, Inc., 2025-12-03, $4M EDGAR↗
  • FibroBiologics, Inc., 2025-12-03, $1.5M EDGAR↗

Other Form D filings from the same week

each with its own page and its own EDGAR source